InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Severino Michael, Vice-Président. Officer active across 4 companies, notably AbbVie Inc.. Aggregated, 13 disclosures have been logged. Activity tracked since 27 December 2021. The latest transaction was disclosed on 6 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Severino Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
756,104 sharesCommon StockSEC:0001193125-26-324445:0
25,112 shares0Common StockSEC:0001140361-26-008883:0
17,100 shares0Common StockSEC:0001722482-25-000145:0
8,477 shares0Common StockSEC:0001722482-24-000113:0
9,808 shares0Common StockSEC:0001722482-23-000121:0
46,320 shares@ US$114.3627.3% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-003137:0
70,879 shares@ US$61.3622.9% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-003077:0
6,693 shares0Common StockSEC:0001722482-22-000131:0
74,309 shares@ US$54.4421.1% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-002947:0
1,215 shares0Common StockSEC:0001722482-22-000081:0
38,857 shares@ US$149.5428.6% of flowCommon Stock, $0.01 par valueSEC:0001179110-22-001829:0
48,198 shares0Common Stock, $0.01 par valueSEC:0001179110-22-001507:0
583 shares0Common Stock, $0.01 par valueSEC:0001179110-21-011274:0
13 of 13 declarations
About Severino Michael
SEVERINO MICHAEL is Vice-Président. He is associated with AbbVie Inc., Avantor, Inc., Sarepta Therapeutics, Inc. and Viatris Inc. The 13 filings on record cover the period from 2021-12-30 to 2026-07-29 in the recent sample, with transaction nature Attribution; the aggregated buy and sell amounts are 0 and 0 in this sample. Recent filings include amounts of 5192419.66556284, 4958931.849465492, 4166254.209149305 and 3838217.864609483 for AbbVie Inc., as well as 0 for Viatris Inc., and one record with no amount indicated for Sarepta Therapeutics, Inc.
